Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive:

JHOP Print Edition

JHOP Weekly e‑Newsletter

I have reviewed and consent to the terms of JHOP's Privacy Policy, and JHOP has my permission to retain my information in its database, and to forward pertinent communications to me.

Case Reports

A Pregnant 19-Year-Old Patient with Refractory Immune Thrombocytopenia and Concomitant SARS-CoV-2 Infection: Case Report

Rebecca Rezac, PharmD, and Jaimie Wittig, PharmD, BCOP

Anakinra Used in a Patient with Diffuse Large B-Cell Lymphoma and Steroid-Refractory Immune Effector Cell–Associated Neurotoxicity Syndrome: Case Report

Drew A. Wells, PharmD, BCPS; Kori Holman, PharmD, BCOP; Brion Randolph, MD; Dennis Marjoncu, PharmD, BCOP

Neoadjuvant FOLFIRINOX Therapy for a Patient with Borderline Resectable Pancreatic Ductal Adenocarcinoma Undergoing Hemodialysis: Case Report

Mark E. Jao, PharmD; Kathyrn S. Lee, PharmD, BCOP; Shannon Jeong, PharmD; Reid Nakagawa, PharmD; Eve-Michelle Segal, PharmD, BCOP; Stacey Cohen, MD

The Presence of De Novo EGFR T790M Mutation in a Tyrosine Kinase Inhibitor–Naïve Patient with Lung Adenocarcinoma: Case Report and Review of the Literature

Jessica Katiaj, PharmD; Rosemary Boshar, PharmD; Maryann R. Cooper, PharmD, BCOP; Gerald Gehr, MD

Isavuconazonium Sulfate Dosing in Pediatric Patients Using Serum Therapeutic Drug Monitoring at a Single Center: A Case Series

Ashley M. Martin, PharmD; Christine E. MacBrayne, PharmD, MSCS, BCIDP; Alyssa Heiden, PharmD; Jason Child, PharmD; Donna J. Curtis, MD, MPH; Andrew S. Haynes, MD

Complete Pathologic Response to Pembrolizumab in a Patient with Cutaneous Angiosarcoma: Case Report

Michael J. Nathenson, MD, and Jason L. Hornick, MD, PhD

Third-Line Tyrosine Kinase Inhibitor Therapy Results in 16-Year Remission in a Patient with Stage IV Non–Small-Cell Lung Cancer

Carrie L. Barnhart, PharmD, BCOP, and David F. Christianson, MD

Managing Resistant Fusarium Infections in Immunocompromised Pediatric Patients with Malignancy: 2 Case Reports and Review of the Literature

Joshua J. Elder, PharmD, BCPS, BCOP; Kyle A. Harwood, PharmD, BCPPS; Savannah L. Gulley, PharmD, BCPPS; Lisa M. Infanti, PharmD, BCCCP; Mason T. Holt, PharmD

Arsenic Trioxide–Induced QTc Interval Prolongation and the Potential Benefit of Beta-Blockers in Patients with Acute Promyelocytic Leukemia: Case Series

Nada Alsuhebany, BSPharmD, PharmD, BCOP; Marti Larriva, PharmD, BCPS, BCOP; Ali McBride, PharmD, MS, BCPS, BCOP, FASHP; Krisstina Gowin, DO

New Formulation of Bendamustine Associated with Phlebitis: Report of 2 Unique Patient Cases

Veronica Ajewole, PharmD, BCOP; Lindsay Edmondson, PharmD, BCOP; Edward McLean, PharmD, BCOP; Kirk Heyne, MD; Lawrence Rice, MD

Page 1 of 4
Results 1 - 10 of 32